Thursday, December 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Rigetti Shares Plunge as Valuation Concerns Mount

Robert Sasse by Robert Sasse
October 22, 2025
in AI & Quantum Computing, Nasdaq, Tech & Software, Trading & Momentum
0
Rigetti Computing Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Rigetti Computing’s stock is experiencing a severe downturn, marking a dramatic reversal from its previous bullish trajectory. The quantum computing company’s shares have come under intense selling pressure following a period of exceptional gains, with recent trading sessions showing significant deterioration in investor sentiment. Critical technical support levels are now being tested as the decline accelerates.

Sustained Decline on Heavy Volume

The equity has entered a pronounced downward trend, recording losses for four consecutive trading days. This correction phase has been accompanied by unusually high trading activity exceeding $3 billion, highlighting a substantial shift in market dynamics. The previously relentless upward momentum appears to be collapsing under growing concerns about the company’s valuation metrics.

Market technicians are closely monitoring the stock’s interaction with its 20-day moving average, which now represents a crucial technical inflection point. A decisive break below this level could signal further downside potential, with analysts identifying possible support zones around $34.50 and potentially even $30 if the current level fails to hold.

Should investors sell immediately? Or is it worth buying Rigetti Computing?

Fundamental Weakness Emerges

The sharp price correction is forcing investors to scrutinize Rigetti’s underlying financial performance, which presents several challenging aspects:

  • Revenue vs. Valuation Disconnect: Despite a year-long rally that propelled the company’s market capitalization to nearly $17 billion, annual revenue remains just over $8 million.
  • Quarterly Performance Deterioration: Second-quarter 2025 results revealed a significant revenue decline to $1.8 million, compared to $3.1 million in the same quarter last year.
  • Compressing Margins: Gross margins also contracted sharply to 31% in Q2, down from 64% during the comparable period last year.

This growing divergence between market valuation and operational performance has led market observers to characterize the previous advance as a “quantum bubble” driven more by speculative enthusiasm than fundamental business results. Additional negative signals include a sell indicator triggered on October 15, after which the stock began its substantial descent. Insider sentiment is currently rated as negative, further contributing to the bearish outlook.

Ad

Rigetti Computing Stock: Buy or Sell?! New Rigetti Computing Analysis from December 11 delivers the answer:

The latest Rigetti Computing figures speak for themselves: Urgent action needed for Rigetti Computing investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 11.

Rigetti Computing: Buy or sell? Read more here...

Tags: Rigetti Computing
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

XRP Stock
Analysis

XRP Faces a Supply Crunch as Institutional Demand Soars

December 11, 2025
BellRing Brands, Stock
Analysis

BellRing Brands Stock Shows Resilience Amid Legal Scrutiny

December 10, 2025
Intel Stock
AI & Quantum Computing

Intel’s Strategic Moves Face Market Scrutiny Amid AI Push

December 10, 2025
Next Post
Arrowhead Stock

Arrowhead Pharmaceuticals: A Biotech Contender's Strategic Ascent

Affirm Holdings Stock

Affirm Stock: Strategic Moves Position BNPL Leader for Critical Holiday Season

Sarepta Therapeutics Stock

Sarepta Therapeutics: Institutional Bets and Clinical Breakthroughs Fuel Optimism

Recommended

Cellectar Stock

Cellectar Shares Show Promise Amid Regulatory Advances

1 month ago
Qualcomm Stock

Qualcomm’s Strategic Pivot: Challenging AI Dominance with Billion-Dollar Deal

1 month ago
Ethereum Stock

Ethereum’s Resurgence: Network Strength Meets Institutional Pressure

1 month ago
C3.ai Stock

C3.ai Shares Plunge Amid Mounting Challenges

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

NASA Contract Bolsters Investor Confidence in Plug Power

Gold Nears Record Territory as Central Bank Moves and Demand Converge

Nel ASA Strengthens Project Leadership Amid Strong Order Intake

Ballard Power: A Cautious Market Appraises Operational Gains

XRP Faces a Supply Crunch as Institutional Demand Soars

Standard Lithium’s Funding Milestone: A Critical Juncture for Arkansas Project

Trending

Assembly Biosciences Stock
Analysis

Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades

by Andreas Sommer
December 11, 2025
0

Growing optimism surrounds Assembly Biosciences following the release of compelling interim data from its Phase 1b study...

Nio Stock

Nio Shares Seek a Firmer Foundation After Steep Decline

December 11, 2025
Vulcan Energy Stock

Vulcan Energy Secures Full Funding and Key Site for Lithium Project

December 11, 2025
Plug Power Stock

NASA Contract Bolsters Investor Confidence in Plug Power

December 11, 2025
Gold Stock

Gold Nears Record Territory as Central Bank Moves and Demand Converge

December 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades
  • Nio Shares Seek a Firmer Foundation After Steep Decline
  • Vulcan Energy Secures Full Funding and Key Site for Lithium Project

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com